Logo image of CSAN

COSAN SA -ADR (CSAN) Stock Fundamental Analysis

USA - NYSE:CSAN - US22113B1035 - ADR

4.57 USD
+0.12 (+2.7%)
Last: 10/31/2025, 3:01:08 PM
Fundamental Rating

4

CSAN gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 121 industry peers in the Specialty Retail industry. While CSAN is still in line with the averages on profitability rating, there are concerns on its financial health. CSAN scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year CSAN has reported negative net income.
In the past year CSAN had a positive cash flow from operations.
CSAN had positive earnings in 4 of the past 5 years.
Each year in the past 5 years CSAN had a positive operating cash flow.
CSAN Yearly Net Income VS EBIT VS OCF VS FCFCSAN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B 10B

1.2 Ratios

CSAN has a Return On Assets of -9.31%. This is in the lower half of the industry: CSAN underperforms 75.21% of its industry peers.
CSAN has a worse Return On Equity (-163.24%) than 75.21% of its industry peers.
Looking at the Return On Invested Capital, with a value of 6.48%, CSAN is in the better half of the industry, outperforming 63.64% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CSAN is significantly below the industry average of 11.81%.
The last Return On Invested Capital (6.48%) for CSAN is above the 3 year average (4.36%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -9.31%
ROE -163.24%
ROIC 6.48%
ROA(3y)-1.67%
ROA(5y)0.73%
ROE(3y)-25.17%
ROE(5y)-5.22%
ROIC(3y)4.36%
ROIC(5y)4.21%
CSAN Yearly ROA, ROE, ROICCSAN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60 -80

1.3 Margins

With an excellent Operating Margin value of 20.98%, CSAN belongs to the best of the industry, outperforming 98.35% of the companies in the same industry.
In the last couple of years the Operating Margin of CSAN has declined.
CSAN's Gross Margin of 31.48% is on the low side compared to the rest of the industry. CSAN is outperformed by 61.98% of its industry peers.
CSAN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 20.98%
PM (TTM) N/A
GM 31.48%
OM growth 3Y3.25%
OM growth 5Y-3.69%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.35%
GM growth 5Y1.27%
CSAN Yearly Profit, Operating, Gross MarginsCSAN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

3

2. Health

2.1 Basic Checks

CSAN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for CSAN has been reduced compared to 1 year ago.
CSAN has more shares outstanding than it did 5 years ago.
CSAN has a worse debt/assets ratio than last year.
CSAN Yearly Shares OutstandingCSAN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
CSAN Yearly Total Debt VS Total AssetsCSAN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B

2.2 Solvency

CSAN has an Altman-Z score of 0.74. This is a bad value and indicates that CSAN is not financially healthy and even has some risk of bankruptcy.
CSAN has a Altman-Z score of 0.74. This is in the lower half of the industry: CSAN underperforms 73.55% of its industry peers.
The Debt to FCF ratio of CSAN is 17.68, which is on the high side as it means it would take CSAN, 17.68 years of fcf income to pay off all of its debts.
CSAN has a Debt to FCF ratio of 17.68. This is comparable to the rest of the industry: CSAN outperforms 50.41% of its industry peers.
CSAN has a Debt/Equity ratio of 8.61. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of CSAN (8.61) is worse than 80.99% of its industry peers.
Industry RankSector Rank
Debt/Equity 8.61
Debt/FCF 17.68
Altman-Z 0.74
ROIC/WACC0.98
WACC6.61%
CSAN Yearly LT Debt VS Equity VS FCFCSAN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.3 Liquidity

A Current Ratio of 1.83 indicates that CSAN should not have too much problems paying its short term obligations.
CSAN's Current ratio of 1.83 is amongst the best of the industry. CSAN outperforms 80.17% of its industry peers.
A Quick Ratio of 1.68 indicates that CSAN should not have too much problems paying its short term obligations.
CSAN has a better Quick ratio (1.68) than 88.43% of its industry peers.
Industry RankSector Rank
Current Ratio 1.83
Quick Ratio 1.68
CSAN Yearly Current Assets VS Current LiabilitesCSAN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

4

3. Growth

3.1 Past

The earnings per share for CSAN have decreased strongly by -781.03% in the last year.
The Revenue has been growing slightly by 7.91% in the past year.
CSAN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 26.51% yearly.
EPS 1Y (TTM)-781.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-325%
Revenue 1Y (TTM)7.91%
Revenue growth 3Y20.84%
Revenue growth 5Y26.51%
Sales Q2Q%-2.02%

3.2 Future

The Earnings Per Share is expected to grow by 39.10% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 0.14% on average over the next years.
EPS Next Y83.7%
EPS Next 2Y56.02%
EPS Next 3Y39.1%
EPS Next 5YN/A
Revenue Next Year-3.86%
Revenue Next 2Y-1.31%
Revenue Next 3Y0.14%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CSAN Yearly Revenue VS EstimatesCSAN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50B 100B 150B
CSAN Yearly EPS VS EstimatesCSAN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 5 -5 -10

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CSAN. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 3.99, which indicates a rather cheap valuation of CSAN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CSAN indicates a rather cheap valuation: CSAN is cheaper than 99.17% of the companies listed in the same industry.
CSAN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.50.
Industry RankSector Rank
PE N/A
Fwd PE 3.99
CSAN Price Earnings VS Forward Price EarningsCSAN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

90.08% of the companies in the same industry are more expensive than CSAN, based on the Enterprise Value to EBITDA ratio.
CSAN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CSAN is cheaper than 98.35% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.03
EV/EBITDA 4.49
CSAN Per share dataCSAN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15

4.3 Compensation for Growth

CSAN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CSAN's earnings are expected to grow with 39.10% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y56.02%
EPS Next 3Y39.1%

5

5. Dividend

5.1 Amount

CSAN has a Yearly Dividend Yield of 2.44%.
CSAN's Dividend Yield is rather good when compared to the industry average which is at 5.20. CSAN pays more dividend than 84.30% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.33, CSAN has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.44%

5.2 History

The dividend of CSAN is nicely growing with an annual growth rate of 25.09%!
CSAN has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)25.09%
Div Incr Years0
Div Non Decr Years0
CSAN Yearly Dividends per shareCSAN Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 0.5 1

5.3 Sustainability

CSAN has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of CSAN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-25.08%
EPS Next 2Y56.02%
EPS Next 3Y39.1%
CSAN Yearly Income VS Free CF VS DividendCSAN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B

COSAN SA -ADR

NYSE:CSAN (10/31/2025, 3:01:08 PM)

4.57

+0.12 (+2.7%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)08-13 2025-08-13/amc
Earnings (Next)11-12 2025-11-12
Inst Owners20.74%
Inst Owner Change-0.3%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.12B
Revenue(TTM)43.55B
Net Income(TTM)-11738450000
Analysts78.82
Price Target5.56 (21.66%)
Short Float %1.33%
Short Ratio2.05
Dividend
Industry RankSector Rank
Dividend Yield 2.44%
Yearly Dividend1.37
Dividend Growth(5Y)25.09%
DP-25.08%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-812.09%
Min EPS beat(2)-1027.4%
Max EPS beat(2)-596.78%
EPS beat(4)0
Avg EPS beat(4)-744.76%
Min EPS beat(4)-1285.85%
Max EPS beat(4)-69.01%
EPS beat(8)1
Avg EPS beat(8)-367.61%
EPS beat(12)2
Avg EPS beat(12)-257.65%
EPS beat(16)4
Avg EPS beat(16)-198.12%
Revenue beat(2)0
Avg Revenue beat(2)-75.19%
Min Revenue beat(2)-76.92%
Max Revenue beat(2)-73.47%
Revenue beat(4)0
Avg Revenue beat(4)-74.24%
Min Revenue beat(4)-76.92%
Max Revenue beat(4)-72.24%
Revenue beat(8)0
Avg Revenue beat(8)-55.64%
Revenue beat(12)0
Avg Revenue beat(12)-51.45%
Revenue beat(16)0
Avg Revenue beat(16)-57.72%
PT rev (1m)-14.33%
PT rev (3m)-7.13%
EPS NQ rev (1m)-8.59%
EPS NQ rev (3m)-33.74%
EPS NY rev (1m)0.02%
EPS NY rev (3m)-132.83%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.18%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-7.25%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 3.99
P/S 0.26
P/FCF 3.03
P/OCF 0.91
P/B 1.59
P/tB N/A
EV/EBITDA 4.49
EPS(TTM)-3.52
EYN/A
EPS(NY)1.14
Fwd EY25.04%
FCF(TTM)1.51
FCFY32.97%
OCF(TTM)5.04
OCFY110.23%
SpS17.38
BVpS2.87
TBVpS-7.7
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -9.31%
ROE -163.24%
ROCE 8.21%
ROIC 6.48%
ROICexc 7.59%
ROICexgc 10.52%
OM 20.98%
PM (TTM) N/A
GM 31.48%
FCFM 8.67%
ROA(3y)-1.67%
ROA(5y)0.73%
ROE(3y)-25.17%
ROE(5y)-5.22%
ROIC(3y)4.36%
ROIC(5y)4.21%
ROICexc(3y)5.12%
ROICexc(5y)5.21%
ROICexgc(3y)6.64%
ROICexgc(5y)7.56%
ROCE(3y)5.52%
ROCE(5y)5.33%
ROICexgc growth 3Y5.58%
ROICexgc growth 5Y-20.62%
ROICexc growth 3Y6.6%
ROICexc growth 5Y-13.61%
OM growth 3Y3.25%
OM growth 5Y-3.69%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.35%
GM growth 5Y1.27%
F-Score6
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 8.61
Debt/FCF 17.68
Debt/EBITDA 4.71
Cap/Depr 221.51%
Cap/Sales 20.32%
Interest Coverage 1.74
Cash Conversion 96.15%
Profit Quality N/A
Current Ratio 1.83
Quick Ratio 1.68
Altman-Z 0.74
F-Score6
WACC6.61%
ROIC/WACC0.98
Cap/Depr(3y)179.81%
Cap/Depr(5y)178.28%
Cap/Sales(3y)15.09%
Cap/Sales(5y)13.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-781.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-325%
EPS Next Y83.7%
EPS Next 2Y56.02%
EPS Next 3Y39.1%
EPS Next 5YN/A
Revenue 1Y (TTM)7.91%
Revenue growth 3Y20.84%
Revenue growth 5Y26.51%
Sales Q2Q%-2.02%
Revenue Next Year-3.86%
Revenue Next 2Y-1.31%
Revenue Next 3Y0.14%
Revenue Next 5YN/A
EBIT growth 1Y48.56%
EBIT growth 3Y24.77%
EBIT growth 5Y21.84%
EBIT Next Year104.25%
EBIT Next 3Y34.35%
EBIT Next 5YN/A
FCF growth 1Y-35.46%
FCF growth 3Y65.47%
FCF growth 5Y21.36%
OCF growth 1Y14.86%
OCF growth 3Y35.81%
OCF growth 5Y36.03%

COSAN SA -ADR / CSAN FAQ

What is the ChartMill fundamental rating of COSAN SA -ADR (CSAN) stock?

ChartMill assigns a fundamental rating of 4 / 10 to CSAN.


What is the valuation status of COSAN SA -ADR (CSAN) stock?

ChartMill assigns a valuation rating of 7 / 10 to COSAN SA -ADR (CSAN). This can be considered as Undervalued.


Can you provide the profitability details for COSAN SA -ADR?

COSAN SA -ADR (CSAN) has a profitability rating of 4 / 10.


Can you provide the expected EPS growth for CSAN stock?

The Earnings per Share (EPS) of COSAN SA -ADR (CSAN) is expected to grow by 83.7% in the next year.